Lataa...
SAT-674 Anti PD1 Induced Type 1 Diabetes
Introduction: Pembrolizumab t is used to treat various cancers. It is associated with immune related adverse events (IRAEs) that can be life threatening [1,4]. We describe a patient who presented autoimmune Diabetes after the use of Pembrolizumab. Case: 64 y/o African American female PMHX of lung no...
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208844/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.412 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|